Gene | Patients (n = 438) | No. of events (%) | MST (days) | Crude HR (95% CI) | Crude P | Adjusted HR* (95% CI) | Adjusted P* |
---|---|---|---|---|---|---|---|
GSTM1 | |||||||
High | 219 | 57 (26.0%) | 1849 | Ref. | 0.018 | Ref. | 0.006 |
Low | 219 | 41 (18.7%) | 3042 | 0.614 (0.410–0.919) | 0.559 (0.367–0.849) | ||
GSTM2 | |||||||
High | 219 | 59 (26.9%) | 2047 | Ref. | 0.003 | Ref. | 0.002 |
Low | 219 | 39 (17.8%) | 2821 | 0.545 (0.364–0.818) | 0.519 (0.342–0.790) | ||
GSTM3 | |||||||
High | 219 | 45 (20.5%) | 3042 | Ref. | 0.804 | Ref. | 0.469 |
Low | 219 | 53 (24.3%) | 2134 | 0.804 (0.540–1.197) | 0.860 (0.571–1.295) | ||
GSTM4 | |||||||
High | 219 | 46 (21.0%) | 3042 | Ref. | 0.387 | Ref. | 0.729 |
Low | 219 | 52 (23.7%) | 2134 | 0.839 (0.563–1.249) | 0.930 (0.618–1.400) | ||
GSTM5 | |||||||
High | 219 | 53 (24.2%) | 2134 | Ref. | 0.495 | Ref. | 0.903 |
Low | 219 | 45 (20.5%) | 2821 | 1.148 (0.772–1.709) | 0.975 (0.647–1.468) |